piperacillin has been researched along with Cystic Fibrosis of Pancreas in 72 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 27 (37.50) | 18.7374 |
1990's | 9 (12.50) | 18.2507 |
2000's | 10 (13.89) | 29.6817 |
2010's | 22 (30.56) | 24.3611 |
2020's | 4 (5.56) | 2.80 |
Authors | Studies |
---|---|
Alba, L; Chen, Y; Garber, E; Saiman, L; Tabibi, S; Zhou, J | 1 |
Bulitta, JB; Drusano, GL; Duffull, SB; Holzgrabe, U; Kinzig-Schippers, M; Sörgel, F; Stephan, U | 1 |
Christiansen, LE; Ciofu, O; Høiby, N; Kirkby, N; Mandsberg, LF; Poulsen, HE | 1 |
Hancock, RE; Kiffer, CR; Mendes, CM; Sampaio, JL; Schurek, KN; Sinto, S | 1 |
Brockow, K; de Monestrol, I; Gülen, T; Kowalik, A; Sorjonen, K | 1 |
Güler, N; Süleyman, A; Tamay, Z | 1 |
Engdahl, S; Pettit, RS; Riggsbee, D | 1 |
Demuyser, T; Echahidi, F; Olbrecht, M; Peeters, C; Piérard, D; Vandamme, P; Wybo, I | 1 |
Caverly, LJ; Huang, DB; Kalikin, LM; LiPuma, JJ; Spilker, T; Stillwell, T; Young, C | 1 |
Mayer, B; Roehmel, J; Salama, A; Schwarz, C; Specht, P; Staab, D | 1 |
LeCleir, LK; Pettit, RS | 1 |
Carlier, M; De Baets, F; Forier, K; Haerynck, F; Schelstraete, P; Stove, V; Van Braeckel, E; Van Daele, S; Van Heck, V; Van Simaey, L; Vaneechoutte, M; Verstraete, AG | 1 |
Barnes, MD; Becka, SA; LiPuma, JJ; Papp-Wallace, KM; Wilson, BM; Zeiser, ET | 1 |
El-Ghaiesh, S; Farrell, J; Hamlett, J; Jenkins, RE; Meng, X; Monshi, MM; Naisbitt, DJ; Park, BK; Peckham, D; Pirmohamed, M; Sanderson, JP; Whitaker, P; Yaseen, FS | 1 |
Peckham, D; Whitaker, P | 1 |
Beegle, S; Butterfield, JM; Farkas, J; Lodise, TP; Pai, MP; Rosen, J | 1 |
Aghazadeh, M; Hojabri, T; Hojabri, Z; Mahdian, R; Nahaei, MR; Pajand, O; Pirzadeh, T; Rahmati, M | 1 |
Diab Cáceres, L; Girón Moreno, RM; Marcos, MC | 1 |
Adelfred, A; Brock, B; Hardlei, TF; Jensen-Fangel, S; Kragh Thomsen, M; Nejatbakhsh, Y; Öbrink-Hansen, K; Petersen, E | 1 |
Mayer, B; Meinus, C; Roehmel, JF; Schwarz, C | 1 |
Brockhurst, MA; Davies, EV; James, CE; Winstanley, C | 1 |
Compain, F; Grohs, P; Kaibi, I; Lavollay, M; Mainardi, JL; Morand, P; Podglajen, I; Taieb, G | 1 |
Hebestreit, H; Kuhn, S; Kunzmann, S; Mayer, B; Thomas, W | 1 |
Cho, E; Davidson, AG; Lillquist, YP | 1 |
Conway, S; Earnshaw, C; El-Ghaiesh, S; Gooi, J; Jenkins, RE; Lavergne, SN; Meng, X; Monshi, M; Naisbitt, DJ; Park, BK; Peckham, D; Pirmohamed, M; Whitaker, P | 1 |
Ciombor, KK; Gehrie, E; Harris, N; Neff, AT; Seegmiller, AC; Young, PP | 1 |
El-Ghaiesh, S; Elsheikh, A; Farrell, J; French, N; Jenkins, R; Meng, X; Monshi, MM; Naisbitt, DJ; Park, BK; Peckham, D; Pirmohamed, M; Whitaker, P | 1 |
Naisbitt, D; Peckham, D; Whitaker, P | 1 |
Ampofo, K; Sherwin, CM; Spigarelli, MG; Stockmann, C; Waters, CD; Young, DC; Zobell, JT | 1 |
Marik, PE; Parekh, P | 1 |
Jones, RN; Mutnick, AH; Turner, PJ | 1 |
Arndt, PA; Chandrasekaran, V; Garratty, G; Hill, J; Kasper, M | 1 |
Den Hollander, JG; Jelliffe, RW; Mouton, JW; Overbeek, SE; Vinks, AA | 1 |
Belli, ML; Cruciani, M; Fenu, ML; Manno, G; Romano, L; Ugolotti, E | 1 |
Pitt, TL; Sparrow, M; Stefanidou, M; Warner, M | 1 |
Bertasi, S; Canuzzi, P; Crucitti, G; Grzejdziak, AD; Melis, E; Midulla, F; Quattrucci, S | 1 |
Batten, JC; Hodson, ME; Kennedy, HG; Stead, RJ | 2 |
Brock, PG; Roach, M | 1 |
Strandvik, B | 1 |
Neu, HC; Prince, AS | 2 |
Agostini, M; Barlocco, G; Bonomi, U; Borgo, G; Bozzino, L; Cabrini, G; Cappelletti, LM; Castellani, L; Conforti, M; Mastella, G | 1 |
Babin, S; Blessing-Moore, J; Hsu, YP; Lewiston, NJ; Moss, RB | 1 |
Braverman, S; Goldberg, M; Huang, NN; Keith, H; Palmer, J; Schidlow, D | 1 |
Fleming, PC; Gold, R; Isles, A; Jin, E; Levison, H | 1 |
Cox, FR; Flournoy, DJ | 1 |
Bryan, LE; Godfrey, AJ; Rabin, HR | 1 |
Høiby, N; Møller, NE | 1 |
Eriksen, KR; Feddersen, C; Flensborg, EW; Høiby, N; Møller, NE; Norn, S; Rosendal, K; Schiøtz, PO; Skov, PS | 1 |
Kaneshiro, WM; Lieberman, J | 1 |
Aronoff, SC; Klinger, JD | 1 |
Hoogkamp-Korstanje, JA; van der Laag, J | 1 |
Alpert, SE; Marx, CM | 1 |
Ciofu, O; Giwercman, B; Høiby, N; Pedersen, SS | 1 |
Martin, AJ; Roberts, G; Rye, PJ; Staugas, RE | 1 |
Francis, JL; Henry, RL; Wills, R | 1 |
Bingen, E; Bonacorsi, S; Fitoussi, F; Lhopital, S | 1 |
Fegan, CD; Stableforth, DE; Thickett, KM; Wildman, MJ | 1 |
Dyke, JW; Hay, MB; Kumar, A; Maier, GA | 1 |
Greene, LM; Harwood, IR; Kozakowski-Koch, JA; Rasor, JS | 1 |
Drusano, GL | 1 |
Moss, RB | 1 |
De Boeck, K; Eggermont, E; Smet, M | 1 |
Bentzon, MW; Høiby, N; Jensen, T; Koch, C; Pedersen, SS; Pressler, T; Rosdahl, VT | 1 |
Cambisano, W; Costantini, D; Crossignani, RM; Danza, ML; Giunta, A; Padoan, R; Trezzi, G | 1 |
Black, P; Blumer, J; Craft, JC; Halsey, NA; McCarty, JM; Tilden, SJ; Waring, W | 1 |
Aronoff, SC; Chiesa, C; Labrozzi, PH | 1 |
Grassi, GG | 1 |
Grassi, C | 1 |
Flux, M; Kramer, J; Laferriere, C; Marks, MI; Stutman, HR | 1 |
De Leo, C; Eftimiadi, C; Schito, GC | 1 |
5 review(s) available for piperacillin and Cystic Fibrosis of Pancreas
Article | Year |
---|---|
Drug induced complications; can we do more?
Topics: Administration, Inhalation; Adrenal Cortex Hormones; Aminoglycosides; Anti-Bacterial Agents; Comorbidity; Coronary Disease; Cystic Fibrosis; Diabetes Complications; Diabetes Mellitus; Disease Progression; Drug Hypersensitivity; Exocrine Pancreatic Insufficiency; Humans; Hypoglycemic Agents; Intestines; Magnetic Resonance Imaging; Microbiota; Patient Compliance; Piperacillin | 2013 |
Nonimmediate β-lactam reactions in patients with cystic fibrosis.
Topics: Anti-Bacterial Agents; Ceftazidime; Cell Proliferation; Cystic Fibrosis; Desensitization, Immunologic; Drug Hypersensitivity; Humans; Male; Piperacillin; Skin Tests; T-Lymphocytes | 2012 |
Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: II. cephalosporins and penicillins.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Cefepime; Ceftazidime; Cephalosporins; Clavulanic Acids; Cystic Fibrosis; Disease Progression; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Penicillins; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; Ticarcillin | 2013 |
Respiratory infections: established therapy and its limitations.
Topics: Aged; Anti-Bacterial Agents; Bronchiectasis; Bronchitis; Cystic Fibrosis; Empyema; Humans; Immunologic Deficiency Syndromes; Kinetics; Lung Abscess; Microbial Sensitivity Tests; Penicillin Resistance; Piperacillin; Pleurisy; Pneumonia; Pneumonia, Aspiration; Respiratory Tract Infections | 1985 |
Respiratory infections: clinical evaluation.
Topics: Amikacin; Carbenicillin; Cefotaxime; Cystic Fibrosis; Drug Therapy, Combination; Enterobacteriaceae; Haemophilus influenzae; Humans; Piperacillin; Pseudomonas Infections; Respiratory Tract Infections; Streptococcus; Streptococcus pneumoniae; Tobramycin | 1985 |
10 trial(s) available for piperacillin and Cystic Fibrosis of Pancreas
Article | Year |
---|---|
Systematic comparison of the population pharmacokinetics and pharmacodynamics of piperacillin in cystic fibrosis patients and healthy volunteers.
Topics: Adult; Anti-Bacterial Agents; Case-Control Studies; Computer Simulation; Cystic Fibrosis; Female; Half-Life; Humans; Infusions, Intravenous; Male; Metabolic Clearance Rate; Microbial Sensitivity Tests; Monte Carlo Method; Piperacillin; Population; Pseudomonas aeruginosa; Pseudomonas Infections | 2007 |
Pharmacokinetics and pharmacodynamics of extended-infusion piperacillin/tazobactam in adult patients with cystic fibrosis-related acute pulmonary exacerbations.
Topics: Adult; Anti-Bacterial Agents; Cystic Fibrosis; Female; Humans; Infusions, Intravenous; Male; Microbial Sensitivity Tests; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia, Bacterial; Pseudomonas aeruginosa; Pseudomonas Infections; Serum; Time Factors; Treatment Outcome; Young Adult | 2014 |
Population pharmacokinetic analysis of nonlinear behavior of piperacillin during intermittent or continuous infusion in patients with cystic fibrosis.
Topics: Adult; Area Under Curve; Bayes Theorem; Cystic Fibrosis; Female; Half-Life; Humans; Infusions, Intravenous; Male; Metabolic Clearance Rate; Nonlinear Dynamics; Penicillins; Piperacillin | 2003 |
Alternative antibiotics for the treatment of Pseudomonas infections in cystic fibrosis.
Topics: Adolescent; Alcohol Deterrents; Anti-Bacterial Agents; Azlocillin; Cefoperazone; Cefotaxime; Cefsulodin; Ceftazidime; Cephalosporins; Child; Clinical Trials as Topic; Cystic Fibrosis; Double-Blind Method; Eosinophilia; Humans; Moxalactam; Penicillins; Piperacillin; Pseudomonas Infections; Random Allocation; Respiratory Tract Infections | 1983 |
Comparative efficacy and tolerance study of azlocillin and carbenicillin in patients with cystic fibrosis: a double blind study.
Topics: Adolescent; Adult; Azlocillin; Bacterial Infections; Carbenicillin; Child; Child, Preschool; Clinical Trials as Topic; Cystic Fibrosis; Double-Blind Method; Female; Humans; Lung Diseases; Male; Microbial Sensitivity Tests; Penicillins; Piperacillin | 1983 |
Piperacillin and tobramycin in the treatment of Pseudomonas lung infections in cystic fibrosis.
Topics: Adolescent; Child; Cystic Fibrosis; Drug Therapy, Combination; Humans; Lung Diseases; Piperacillin; Pseudomonas Infections; Tobramycin | 1983 |
Sensitization to aztreonam and cross-reactivity with other beta-lactam antibiotics in high-risk patients with cystic fibrosis.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Antibodies, Anti-Idiotypic; Azlocillin; Aztreonam; Ceftazidime; Child; Child, Preschool; Cross Reactions; Cystic Fibrosis; Drug Hypersensitivity; Female; Humans; Immunoglobulin E; Immunoglobulin G; Male; Piperacillin; Skin Tests; Ticarcillin; Tobramycin | 1991 |
Treatment of Pseudomonas lung infection in cystic fibrosis with piperacillin plus tobramycin versus ceftazidime monotherapy: preliminary communication.
Topics: Ceftazidime; Chronic Disease; Cystic Fibrosis; Drug Combinations; Forced Expiratory Volume; Humans; Leukocyte Count; Lung Diseases; Neutrophils; Piperacillin; Pseudomonas aeruginosa; Pseudomonas Infections; Random Allocation; Tobramycin; Vital Capacity | 1989 |
Ceftazidime monotherapy vs. combined therapy in Pseudomonas pulmonary infections in cystic fibrosis.
Topics: Adolescent; Adult; Analysis of Variance; Ceftazidime; Child; Child, Preschool; Cystic Fibrosis; Drug Therapy, Combination; Female; Humans; Male; Piperacillin; Pneumonia; Prospective Studies; Pseudomonas; Pseudomonas Infections; Random Allocation; Sisomicin; Sputum | 1987 |
Comparison of piperacillin alone versus piperacillin plus tobramycin for treatment of respiratory infections in children with cystic fibrosis.
Topics: Child; Child, Preschool; Cystic Fibrosis; Drug Therapy, Combination; Half-Life; Humans; Infant; Piperacillin; Pseudomonas Infections; Random Allocation; Respiratory Tract Infections; Sputum; Tobramycin | 1988 |
57 other study(ies) available for piperacillin and Cystic Fibrosis of Pancreas
Article | Year |
---|---|
Antimicrobial susceptibility and synergy studies of Burkholderia cepacia complex isolated from patients with cystic fibrosis.
Topics: Anti-Bacterial Agents; Burkholderia cepacia complex; Burkholderia Infections; Cystic Fibrosis; Drug Resistance, Multiple, Bacterial; Drug Synergism; Humans; Microbial Sensitivity Tests | 2007 |
Antibiotic resistance in Pseudomonas aeruginosa strains with increased mutation frequency due to inactivation of the DNA oxidative repair system.
Topics: Cystic Fibrosis; DNA Repair; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Mutation; Neutrophil Activation; Oxidation-Reduction; Oxidative Stress; Pseudomonas aeruginosa | 2009 |
Involvement of pmrAB and phoPQ in polymyxin B adaptation and inducible resistance in non-cystic fibrosis clinical isolates of Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Cystic Fibrosis; Drug Resistance, Multiple, Bacterial; Genotype; Microbial Sensitivity Tests; Polymyxin B; Promoter Regions, Genetic; Pseudomonas aeruginosa; Transcription Factors | 2009 |
Antibiotic hypersensitivity in cystic fibrosis - Low frequency of anaphylaxis over 16 000 courses.
Topics: Adult; Anaphylaxis; Anti-Bacterial Agents; beta-Lactams; Child; Cystic Fibrosis; Drug Hypersensitivity; Humans; Piperacillin; Retrospective Studies | 2022 |
Antibiotic allergy in children with cystic fibrosis: A retrospective case-control study.
Topics: Amikacin; Anti-Bacterial Agents; Azithromycin; Case-Control Studies; Ceftazidime; Child; Ciprofloxacin; Cystic Fibrosis; Drug Hypersensitivity; Humans; Levofloxacin; Meropenem; Piperacillin; Retrospective Studies; Tazobactam; Trimethoprim, Sulfamethoxazole Drug Combination | 2022 |
Evaluation of the safety of piperacillin-tazobactam extended infusion in pediatric cystic fibrosis patients.
Topics: Acute Kidney Injury; Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Cystic Fibrosis; Drug Therapy, Combination; Humans; Infant, Newborn; Infusions, Intravenous; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies | 2023 |
Topics: Achromobacter; Anti-Bacterial Agents; Cystic Fibrosis; Humans; Meropenem; Microbial Sensitivity Tests; Piperacillin; Tazobactam | 2023 |
Topics: Achromobacter; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Boronic Acids; Burkholderia; Cystic Fibrosis; Humans; Meropenem; Microbial Sensitivity Tests; Piperacillin; Pseudomonas aeruginosa; Stenotrophomonas; Stenotrophomonas maltophilia; Tazobactam | 2019 |
Risk of piperacillin-induced hemolytic anemia in patients with cystic fibrosis and antipseudomonal treatment: a prospective observational study.
Topics: Adult; Anemia, Hemolytic; Anti-Bacterial Agents; Cystic Fibrosis; Female; Humans; Middle Aged; Observational Studies as Topic; Piperacillin; Prospective Studies | 2019 |
Piperacillin-tazobactam versus cefepime incidence of acute kidney injury in combination with vancomycin and tobramycin in pediatric cystic fibrosis patients.
Topics: Acute Kidney Injury; Adolescent; Anti-Bacterial Agents; Cefepime; Cephalosporins; Child; Cystic Fibrosis; Drug Therapy, Combination; Female; Hospitalization; Humans; Incidence; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Tobramycin; Vancomycin | 2017 |
Development and validation of an LC tandem MS assay for the quantification of β-lactam antibiotics in the sputum of cystic fibrosis patients.
Topics: Anti-Bacterial Agents; Aztreonam; Ceftazidime; Chromatography, High Pressure Liquid; Cystic Fibrosis; Humans; Meropenem; Piperacillin; Sputum; Tandem Mass Spectrometry; Thienamycins | 2018 |
"Switching Partners": Piperacillin-Avibactam Is a Highly Potent Combination against Multidrug-Resistant
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Burkholderia cepacia complex; Burkholderia gladioli; Burkholderia Infections; Cystic Fibrosis; Drug Resistance, Multiple, Bacterial; Drug Substitution; Humans; Kinetics; Microbial Sensitivity Tests; Piperacillin | 2019 |
β-Lactam antibiotics form distinct haptenic structures on albumin and activate drug-specific T-lymphocyte responses in multiallergic patients with cystic fibrosis.
Topics: Aztreonam; beta-Lactamase Inhibitors; beta-Lactams; Cystic Fibrosis; Drug Hypersensitivity; Haptens; Humans; Hypersensitivity; Meropenem; Molecular Structure; Piperacillin; Serum Albumin; T-Lymphocytes; Thienamycins | 2013 |
Role of efflux pumps: MexAB-OprM and MexXY(-OprA), AmpC cephalosporinase and OprD porin in non-metallo-β-lactamase producing Pseudomonas aeruginosa isolated from cystic fibrosis and burn patients.
Topics: Amikacin; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Bacterial Proteins; beta-Lactamases; Burns; Cephalosporinase; Cystic Fibrosis; Drug Resistance, Multiple, Bacterial; Escherichia coli Proteins; Gene Expression Regulation, Bacterial; Humans; Membrane Transport Proteins; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Porins; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam | 2014 |
Cystic Fibrosis and Piperacillin-tazobactam: Adverse Reactions.
Topics: Anti-Bacterial Agents; Cystic Fibrosis; Humans; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Young Adult | 2015 |
Piperacillin/tazobactam continuous infusion at 12G/1.5G per day in CF patients results in target plasma-concentrations.
Topics: Anti-Bacterial Agents; Cystic Fibrosis; Dose-Response Relationship, Drug; Humans; Infusions, Intravenous; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination | 2016 |
Piperacillin-induced mild haemolytic anaemia in a 44-year-old patient with cystic fibrosis.
Topics: Adult; Anemia, Hemolytic; Anti-Bacterial Agents; Cystic Fibrosis; Female; Humans; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination | 2016 |
Evolutionary diversification of Pseudomonas aeruginosa in an artificial sputum model.
Topics: Bacteriophages; beta-Lactamases; Biodiversity; Biofilms; Biological Evolution; Culture Media; Cystic Fibrosis; Drug Resistance, Microbial; Penicillanic Acid; Phenotype; Piperacillin; Pseudomonas aeruginosa; Pseudomonas Infections; Sputum; Tazobactam | 2017 |
Topics: Achromobacter denitrificans; Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Cystic Fibrosis; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Humans; Meropenem; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Stenotrophomonas maltophilia; Tazobactam; Thienamycins | 2017 |
Immune-mediated severe hemolytic crisis with a hemoglobin level of 1.6 g/dl caused by anti-piperacillin antibodies in a patient with cystic fibrosis.
Topics: Anemia, Hemolytic; Anti-Bacterial Agents; Cystic Fibrosis; Drug Hypersensitivity; Female; Hemoglobins; Hemolysis; Humans; Piperacillin; Young Adult | 2010 |
Economic effects of an eradication protocol for first appearance of Pseudomonas aeruginosa in cystic fibrosis patients: 1995 vs. 2009.
Topics: Administration, Oral; Adolescent; Anti-Bacterial Agents; Anti-Infective Agents; Burkholderia cepacia complex; Child; Child, Preschool; Ciprofloxacin; Cohort Studies; Colistin; Cystic Fibrosis; Disease-Free Survival; Drug Administration Schedule; Drug Therapy, Combination; Health Care Costs; Health Resources; Humans; Infant; Injections, Intravenous; Nebulizers and Vaporizers; Piperacillin; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin; Treatment Outcome | 2011 |
Mass spectrometric characterization of circulating and functional antigens derived from piperacillin in patients with cystic fibrosis.
Topics: Amino Acid Sequence; Antigens; Cell Line; Cell Proliferation; Chromatography, Liquid; Clone Cells; Cystic Fibrosis; Drug Hypersensitivity; Female; Haptens; Humans; Leukocytes, Mononuclear; Male; Molecular Sequence Data; Peptide Fragments; Peptides, Cyclic; Piperacillin; Protein Binding; Serum Albumin; Skin Tests; T-Lymphocytes; Tandem Mass Spectrometry | 2011 |
Transfusion medicine illustrated. Profound piperacillin-mediated drug-induced immune hemolysis in a patient with cystic fibrosis.
Topics: Anti-Bacterial Agents; Cystic Fibrosis; Female; Hemoglobins; Hemolysis; Humans; Piperacillin; Pneumonia; Pseudomonas aeruginosa; Pseudomonas Infections; Young Adult | 2012 |
Characterization of the antigen specificity of T-cell clones from piperacillin-hypersensitive patients with cystic fibrosis.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Antigen-Presenting Cells; beta-Lactams; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Chemokine CCL4; Clone Cells; Cystic Fibrosis; Drug Hypersensitivity; Enzyme-Linked Immunosorbent Assay; Epitopes; Female; Humans; Interleukins; Lymphocyte Activation; Male; Mass Spectrometry; Piperacillin; Receptors, Antigen, T-Cell; Young Adult | 2012 |
Life-threatening piperacillin-induced immune haemolysis in a patient with cystic fibrosis.
Topics: Anemia, Hemolytic, Autoimmune; Anti-Bacterial Agents; Cystic Fibrosis; Humans; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Young Adult | 2013 |
Emerging antimicrobial resistances among Proteus mirabilis in Europe: report from the MYSTIC Program (1997-2001). Meropenem Yearly Susceptibility Test Information Collection.
Topics: Anti-Bacterial Agents; Cefepime; Ceftazidime; Cephalosporins; Ciprofloxacin; Critical Care; Cystic Fibrosis; Data Collection; Drug Resistance, Bacterial; Europe; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Neutropenia; Penicillanic Acid; Piperacillin; Population Surveillance; Proteus Infections; Proteus mirabilis; Tazobactam; Thienamycins | 2002 |
Two cases of immune haemolytic anaemia, associated with anti-piperacillin, detected by the 'immune complex' method.
Topics: Adult; Anemia, Hemolytic; Antibodies; Coombs Test; Cystic Fibrosis; Drug Hypersensitivity; Fatal Outcome; Humans; Male; Piperacillin; Serologic Tests | 2002 |
Use of the E test to assess synergy of antibiotic combinations against isolates of Burkholderia cepacia-complex from patients with cystic fibrosis.
Topics: Bacteriological Techniques; Burkholderia cepacia; Burkholderia Infections; Ceftazidime; Chi-Square Distribution; Child; Child, Preschool; Ciprofloxacin; Cystic Fibrosis; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Female; Humans; Lactams; Male; Microbial Sensitivity Tests; Piperacillin; Rifampin; Sensitivity and Specificity | 2003 |
Survey of resistance of Pseudomonas aeruginosa from UK patients with cystic fibrosis to six commonly prescribed antimicrobial agents.
Topics: Adult; Anti-Bacterial Agents; Ceftazidime; Ciprofloxacin; Colistin; Cystic Fibrosis; Drug Resistance, Bacterial; Gentamicins; Humans; Piperacillin; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin | 2003 |
Spondylodiscitis after bilateral sequential lung transplantation in a patient with cystic fibrosis.
Topics: Adult; Ampicillin; Anti-Bacterial Agents; Cystic Fibrosis; Discitis; Female; Humans; Lung Transplantation; Piperacillin; Streptococcal Infections; Streptococcus; Treatment Outcome | 2004 |
Adverse reactions to piperacillin in cystic fibrosis.
Topics: Adult; Cystic Fibrosis; Female; Fever; Humans; Male; Piperacillin; Pseudomonas Infections | 1984 |
Adverse reactions to piperacillin in cystic fibrosis.
Topics: Cystic Fibrosis; Drug Hypersensitivity; Humans; Piperacillin | 1984 |
Adverse reactions to piperacillin in patients with cystic fibrosis.
Topics: Adolescent; Adult; Child; Cystic Fibrosis; Female; Humans; Male; Piperacillin; Pseudomonas Infections | 1984 |
Activities of new beta-lactam antibiotics against isolates of Pseudomonas aeruginosa from patients with cystic fibrosis.
Topics: Anti-Bacterial Agents; beta-Lactams; Carbenicillin; Cefoperazone; Cefotaxime; Ceftazidime; Cephalosporins; Cystic Fibrosis; Imipenem; Penicillins; Piperacillin; Pseudomonas aeruginosa; Pseudomonas Infections | 1981 |
Allergy to semisynthetic penicillins in cystic fibrosis.
Topics: Adolescent; Adult; Benzeneacetamides; Carbenicillin; Child; Cystic Fibrosis; Drug Hypersensitivity; Female; Humans; Intradermal Tests; Male; Penicillanic Acid; Penicillin G; Penicillins; Piperacillin; Polylysine; Pseudomonas Infections; Radioallergosorbent Test; Ticarcillin | 1984 |
Ceftazidime alone and in combination in patients with cystic fibrosis: lack of efficacy in treatment of severe respiratory infections caused by Pseudomonas cepacia.
Topics: Adolescent; Ceftazidime; Cephalosporins; Cystic Fibrosis; Drug Combinations; Drug Therapy, Combination; Female; Humans; Male; Piperacillin; Pseudomonas Infections; Respiratory Tract Infections; Sulfamethoxazole; Tobramycin; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1983 |
In vitro susceptibilities of mucoid Pseudomonas aeruginosa isolates from cystic fibrosis patients against azthreonam, netilmicin and piperacillin.
Topics: Anti-Bacterial Agents; Aztreonam; Cystic Fibrosis; Humans; Microbial Sensitivity Tests; Netilmicin; Piperacillin; Pseudomonas aeruginosa | 1984 |
Use of piperacillin, a semisynthetic penicillin, in the therapy of acute exacerbations of pulmonary disease in patients with cystic fibrosis.
Topics: Adolescent; Adult; Alcaligenes; Child; Cystic Fibrosis; Female; Humans; Kinetics; Lung Diseases; Male; Penicillins; Piperacillin; Pseudomonas Infections | 1980 |
beta-Lactam-resistant Pseudomonas aeruginosa with modified penicillin-binding proteins emerging during cystic fibrosis treatment.
Topics: Adolescent; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactams; Carrier Proteins; Cystic Fibrosis; Female; Hexosyltransferases; Humans; Muramoylpentapeptide Carboxypeptidase; Penicillin G; Penicillin Resistance; Penicillin-Binding Proteins; Penicillins; Peptidyl Transferases; Piperacillin; Pseudomonas aeruginosa; Sputum; Tobramycin | 1981 |
Antibiotic treatment of chronic Pseudomonas aeruginosa infection in cystic fibrosis patients.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Azlocillin; Carbenicillin; Child; Child, Preschool; Chronic Disease; Cystic Fibrosis; Humans; Microbial Sensitivity Tests; Penicillins; Piperacillin; Pseudomonas aeruginosa; Pseudomonas Infections | 1981 |
Chemotherapy against Pseudomonas aeruginosa in cystic fibrosis. A study of carbenicillin, azlocillin or piperacillin in combination with tobramycin.
Topics: Anti-Bacterial Agents; Azlocillin; Carbenicillin; Cystic Fibrosis; Drug Therapy, Combination; Humans; Penicillins; Piperacillin; Pseudomonas aeruginosa; Pseudomonas Infections; Recurrence; Tobramycin | 1982 |
Lectin-like factor and co-factor in serum from cystic fibrosis heterozygotes.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Child; Child, Preschool; Chromatography, Gel; Cystic Fibrosis; Genetic Carrier Screening; Humans; Immunoglobulin M; Lectins; Piperacillin; Ticarcillin | 1984 |
In vitro activities of aztreonam, piperacillin, and ticarcillin combined with amikacin against amikacin-resistant Pseudomonas aeruginosa and P. cepacia isolates from children with cystic fibrosis.
Topics: Amikacin; Anti-Bacterial Agents; Aztreonam; Child; Cystic Fibrosis; Drug Therapy, Combination; Humans; Kanamycin; Penicillin Resistance; Piperacillin; Pseudomonas Infections; Ticarcillin | 1984 |
Ticarcillin-induced cystitis. Cross-reactivity with related penicillins.
Topics: Carbenicillin; Child; Child, Preschool; Cross Reactions; Cystic Fibrosis; Cystitis; Hematuria; Humans; Male; Penicillins; Piperacillin; Ticarcillin | 1984 |
Development of antibiotic resistance in Pseudomonas aeruginosa during two decades of antipseudomonal treatment at the Danish CF Center.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbenicillin; Ceftazidime; Ciprofloxacin; Cystic Fibrosis; Denmark; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Piperacillin; Pneumonia, Bacterial; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin | 1994 |
Coagulopathy with piperacillin administration in cystic fibrosis: two case reports.
Topics: Blood Coagulation Disorders; Blood Coagulation Tests; Child; Child, Preschool; Cystic Fibrosis; Drug Eruptions; Female; Humans; Liver Function Tests; Piperacillin; Serum Sickness | 1994 |
Antibiotic hypersensitivity reactions in cystic fibrosis.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Child; Child, Preschool; Cystic Fibrosis; Drug Administration Routes; Drug Hypersensitivity; Female; Humans; Infant; Male; Penicillins; Piperacillin; Respiratory Tract Infections; Retrospective Studies | 1998 |
Comparative in vitro activities of meropenem, imipenem, temocillin, piperacillin, and ceftazidime in combination with tobramycin, rifampin, or ciprofloxacin against Burkholderia cepacia isolates from patients with cystic fibrosis.
Topics: Burkholderia cepacia; Burkholderia Infections; Ceftazidime; Ciprofloxacin; Cystic Fibrosis; Drug Synergism; Drug Therapy, Combination; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Penicillins; Piperacillin; Rifampin; Thienamycins; Tobramycin | 1999 |
Haemolytic anaemia following treatment with piperacillin in a patient with cystic fibrosis.
Topics: Adult; Anemia, Hemolytic; Cystic Fibrosis; Female; Humans; Penicillins; Piperacillin | 1999 |
Post-antibiotic effect of ceftazidime, ciprofloxacin, imipenem, piperacillin and tobramycin for Pseudomonas cepacia.
Topics: Burkholderia cepacia; Ceftazidime; Ciprofloxacin; Cystic Fibrosis; Humans; Imipenem; Microbial Sensitivity Tests; Piperacillin; Tobramycin | 1992 |
New peripherally inserted midline catheter: a better alternative for intravenous antibiotic therapy in patients with cystic fibrosis.
Topics: Adolescent; Adult; Catheterization, Peripheral; Catheters, Indwelling; Ceftazidime; Child; Child, Preschool; Cystic Fibrosis; Drug Therapy, Combination; Elbow; Female; Humans; Imipenem; Infusions, Intravenous; Male; Piperacillin; Time Factors; Tobramycin | 1992 |
Optimal sampling theory and population modelling: application to determination of the influence of the microgravity environment on drug distribution and elimination.
Topics: Bayes Theorem; Ceftazidime; Chromatography, High Pressure Liquid; Ciprofloxacin; Cystic Fibrosis; Fever; Humans; Models, Theoretical; Monte Carlo Method; Neoplasms; Neutropenia; Pharmacokinetics; Piperacillin; Population; Sampling Studies; Weightlessness | 1991 |
Combined imipenem/cilastatin and tobramycin therapy of multiresistant Pseudomonas aeruginosa in cystic fibrosis.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Bronchopneumonia; Child; Chronic Disease; Cilastatin; Cilastatin, Imipenem Drug Combination; Cyclopropanes; Cystic Fibrosis; Drug Combinations; Drug Synergism; Drug Therapy, Combination; Female; Humans; Imipenem; Kinetics; Male; Microbial Sensitivity Tests; Penicillin Resistance; Piperacillin; Pseudomonas aeruginosa; Pseudomonas Infections; Sputum; Thienamycins; Tobramycin | 1987 |
Decreased baseline beta-lactamase production and inducibility associated with increased piperacillin susceptibility of Pseudomonas cepacia isolated from children with cystic fibrosis.
Topics: Analysis of Variance; Aztreonam; beta-Lactamase Inhibitors; beta-Lactamases; Cefoxitin; Ceftazidime; Child; Cystic Fibrosis; Humans; Isoelectric Focusing; Penicillin Resistance; Piperacillin; Pseudomonas; Sputum | 1986 |
Penetration of latamoxef, cefoperazone and piperacillin into the sputum of patients with cystic fibrosis.
Topics: Adolescent; Adult; Cefoperazone; Child; Child, Preschool; Cystic Fibrosis; Humans; Hydrogen-Ion Concentration; Moxalactam; Piperacillin; Pseudomonas aeruginosa; Sputum | 1985 |
Antibacterial activity in vitro of sulbenicillin against mucoid and non-mucoid strains of Pseudomonas aeruginosa.
Topics: Ampicillin; Carbenicillin; Cefotaxime; Cystic Fibrosis; Humans; Methods; Microbial Sensitivity Tests; Penicillin G; Piperacillin; Pseudomonas aeruginosa; Sulbenicillin | 1985 |
Adverse reactions to piperacillin in adults with cystic fibrosis.
Topics: Adult; Azlocillin; Carbenicillin; Cystic Fibrosis; Female; Fever; Humans; Male; Piperacillin; Pseudomonas Infections; Respiratory Tract Infections | 1985 |